Pub Date : 2026-02-05DOI: 10.1177/02676591261423409
Courtney Vidovich, Shawn Tsutsui, Lauren Kirkland, Chelsey Corroto, Marilly Palettas, Alberto Uribe, Rafal Kopanczyk
IntroductionExtracorporeal membrane oxygenation (ECMO) is a high-risk, low-frequency intervention requiring specialized training and effective teamwork, for which simulation-based training is a valuable tool. Across medical disciplines escape room-style simulations have been developed to enhance teamwork and engagement among learners.MethodsWe conducted a prospective observational study at a large academic medical center to evaluate the feasibility and educational impact of an escape room-style ECMO simulation. Thirty-seven nurses completed the escape room simulation. Teamwork was assessed with the Clinical Teamwork Scale (CTS), and effectiveness with the Simulation Effectiveness Tool (SET-M).ResultsObserver-rated CTS scores for overall teamwork (r = -0.76), communication (r = -0.52), and decision-making (r = -0.55) correlated negatively with completion time, suggesting that stronger teamwork was associated with greater efficiency. Participant self-ratings were significantly higher than observer ratings across most domains (p < 0.01), and showed positive correlations with completion times. SET-M results indicated high satisfaction, with all participants reporting improved ECMO knowledge and skills, though prebriefing and debriefing received lower ratings.ConclusionsThese findings support escape room-style simulations as a feasible and engaging approach to ECMO education, with external observation playing a key role in assessing teamwork. Future studies should focus on structured briefing, randomized team assignments, and multidisciplinary cohorts to enhance generalizability and learning outcomes.
{"title":"Extracorporeal membrane oxygenation escape room simulation teamwork dynamics and effectiveness.","authors":"Courtney Vidovich, Shawn Tsutsui, Lauren Kirkland, Chelsey Corroto, Marilly Palettas, Alberto Uribe, Rafal Kopanczyk","doi":"10.1177/02676591261423409","DOIUrl":"https://doi.org/10.1177/02676591261423409","url":null,"abstract":"<p><p>IntroductionExtracorporeal membrane oxygenation (ECMO) is a high-risk, low-frequency intervention requiring specialized training and effective teamwork, for which simulation-based training is a valuable tool. Across medical disciplines escape room-style simulations have been developed to enhance teamwork and engagement among learners.MethodsWe conducted a prospective observational study at a large academic medical center to evaluate the feasibility and educational impact of an escape room-style ECMO simulation. Thirty-seven nurses completed the escape room simulation. Teamwork was assessed with the Clinical Teamwork Scale (CTS), and effectiveness with the Simulation Effectiveness Tool (SET-M).ResultsObserver-rated CTS scores for overall teamwork (r = -0.76), communication (r = -0.52), and decision-making (r = -0.55) correlated negatively with completion time, suggesting that stronger teamwork was associated with greater efficiency. Participant self-ratings were significantly higher than observer ratings across most domains (<i>p</i> < 0.01), and showed positive correlations with completion times. SET-M results indicated high satisfaction, with all participants reporting improved ECMO knowledge and skills, though prebriefing and debriefing received lower ratings.ConclusionsThese findings support escape room-style simulations as a feasible and engaging approach to ECMO education, with external observation playing a key role in assessing teamwork. Future studies should focus on structured briefing, randomized team assignments, and multidisciplinary cohorts to enhance generalizability and learning outcomes.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591261423409"},"PeriodicalIF":1.1,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146120828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.1177/02676591261423026
Akash Shah, Anil Jain, Himani Pandya, Ronak Raval
BackgroundEffective myocardial protection is essential for successful outcomes in open-heart surgery. Although both del Nido and St. Thomas cardioplegia solutions are widely used, comparative evidence in adult rheumatic mitral valve replacement remains limited. This study aimed to compare their myocardial protective efficacy and clinical outcomes.MethodsA prospective comparative study was conducted between May 2022 and October 2024. Total 50 adult patients undergoing mitral valve replacement-20 with severe mitral regurgitation (MR) and 30 with severe mitral stenosis (MS) were included. Patients were divided into two groups based on cardioplegia type (del Nido or St. Thomas). Intraoperative parameters, postoperative left ventricular ejection fraction (LVEF), troponin I levels, inotropic and ventilatory support, and ICU/hospital stay were analysed.ResultsBaseline characteristics were comparable across groups. The mean number of cardioplegia doses was significantly lower in the del Nido group (1.6 ± 0.5 vs 3.2 ± 0.8; p < 0.001). Postoperative LVEF was better preserved with del Nido cardioplegia (MS: 53.3 ± 7.2% vs 45.3 ± 10.6%; p = 0.023). Troponin I levels at 6, 24, and 48 h were lower in the del Nido group, though not statistically significant. Patients receiving del Nido required less inotropic and ventilatory support, with shorter ICU and hospital stays. One in-hospital death occurred in the del Nido group due to sepsis.ConclusionDel Nido cardioplegia offers comparable or superior myocardial protection to St. Thomas solution in adult mitral valve replacement, with fewer interruptions, reduced dosing, and faster postoperative recovery.
{"title":"Outcome of del Nido versus St. Thomas cardioplegia solution in adult mitral valve replacement surgery for rheumatic mitral valve disease.","authors":"Akash Shah, Anil Jain, Himani Pandya, Ronak Raval","doi":"10.1177/02676591261423026","DOIUrl":"https://doi.org/10.1177/02676591261423026","url":null,"abstract":"<p><p>BackgroundEffective myocardial protection is essential for successful outcomes in open-heart surgery. Although both del Nido and St. Thomas cardioplegia solutions are widely used, comparative evidence in adult rheumatic mitral valve replacement remains limited. This study aimed to compare their myocardial protective efficacy and clinical outcomes.MethodsA prospective comparative study was conducted between May 2022 and October 2024. Total 50 adult patients undergoing mitral valve replacement-20 with severe mitral regurgitation (MR) and 30 with severe mitral stenosis (MS) were included. Patients were divided into two groups based on cardioplegia type (del Nido or St. Thomas). Intraoperative parameters, postoperative left ventricular ejection fraction (LVEF), troponin I levels, inotropic and ventilatory support, and ICU/hospital stay were analysed.ResultsBaseline characteristics were comparable across groups. The mean number of cardioplegia doses was significantly lower in the del Nido group (1.6 ± 0.5 vs 3.2 ± 0.8; <i>p</i> < 0.001). Postoperative LVEF was better preserved with del Nido cardioplegia (MS: 53.3 ± 7.2% vs 45.3 ± 10.6%; <i>p</i> = 0.023). Troponin I levels at 6, 24, and 48 h were lower in the del Nido group, though not statistically significant. Patients receiving del Nido required less inotropic and ventilatory support, with shorter ICU and hospital stays. One in-hospital death occurred in the del Nido group due to sepsis.ConclusionDel Nido cardioplegia offers comparable or superior myocardial protection to St. Thomas solution in adult mitral valve replacement, with fewer interruptions, reduced dosing, and faster postoperative recovery.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591261423026"},"PeriodicalIF":1.1,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146114682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectiveCardiopulmonary bypass (CPB), which induces pulmonary injury, significantly impacts the quality of life in patients undergoing cardiac surgery. Preventing and treating pulmonary complications has become a critical clinical issue. Optimizing ventilation strategies during the preoperative, intraoperative, and postoperative stages is essential for adequate lung protection and preventing CPB-related pulmonary injury.MethodsA comprehensive search of multiple databases including PubMed, Embase, and the Cochrane Library was conducted. After removing the duplicate studies, full-text review was performed, and all studies that reported mechanical ventilation strategies and lung protection during CPB were included.ResultsThis review systematically examines ventilation strategies during CPB, outlining optimized parameters and pharmacologic approaches across pre-, intra-, and post-CPB phases to reduce lung injury. Various modes - including volume control ventilation (VCV), pressure control ventilation (PCV), and pressure-controlled ventilation-volume guaranteed (PCV-VG) - demonstrate unique benefits and limitations. When combined with protective measures (low tidal volume [LTV], moderate positive end-expiratory pressure [PEEP], and recruitment maneuvers), they show clinical efficacy in lung protection. Pharmacologic agents like ambroxol, neutrophil elastase inhibitors, and sivelestat further enhance protection, underscoring the promise of combined mechanical-pharmacological strategies against CPB-induced lung injury.ConclusionsA comprehensive approach integrating individualized ventilation management and pharmacological intervention is key to reducing CPB-induced lung injury, enhancing postoperative respiratory function, and improving patient outcomes.
{"title":"Mechanical ventilation strategies and lung protection during cardiopulmonary bypass: A scoping review.","authors":"Yue Wang, Sijie Lu, Xiaoqian Zhang, Chuhan Huang, Yongnan Li, Nan Zhang","doi":"10.1177/02676591261423003","DOIUrl":"https://doi.org/10.1177/02676591261423003","url":null,"abstract":"<p><p>ObjectiveCardiopulmonary bypass (CPB), which induces pulmonary injury, significantly impacts the quality of life in patients undergoing cardiac surgery. Preventing and treating pulmonary complications has become a critical clinical issue. Optimizing ventilation strategies during the preoperative, intraoperative, and postoperative stages is essential for adequate lung protection and preventing CPB-related pulmonary injury.MethodsA comprehensive search of multiple databases including PubMed, Embase, and the Cochrane Library was conducted. After removing the duplicate studies, full-text review was performed, and all studies that reported mechanical ventilation strategies and lung protection during CPB were included.ResultsThis review systematically examines ventilation strategies during CPB, outlining optimized parameters and pharmacologic approaches across pre-, intra-, and post-CPB phases to reduce lung injury. Various modes - including volume control ventilation (VCV), pressure control ventilation (PCV), and pressure-controlled ventilation-volume guaranteed (PCV-VG) - demonstrate unique benefits and limitations. When combined with protective measures (low tidal volume [LTV], moderate positive end-expiratory pressure [PEEP], and recruitment maneuvers), they show clinical efficacy in lung protection. Pharmacologic agents like ambroxol, neutrophil elastase inhibitors, and sivelestat further enhance protection, underscoring the promise of combined mechanical-pharmacological strategies against CPB-induced lung injury.ConclusionsA comprehensive approach integrating individualized ventilation management and pharmacological intervention is key to reducing CPB-induced lung injury, enhancing postoperative respiratory function, and improving patient outcomes.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591261423003"},"PeriodicalIF":1.1,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-31DOI: 10.1177/02676591261416014
Daniel Joelsons, Leonardo Van de Wiel Barros Urbano Andari, Pedro Paulo Zanella do Amaral Campos, Caroline Gomes Mól, Bruno de Arruda Bravim, Giles J Peek
IntroductionExtracorporeal membrane oxygenation (ECMO) involves the use of a synthetic circuit, which initiates a complex interplay of inflammatory and pro-coagulant responses. This intricate, self-reinforcing process results in a prothrombotic state, predisposing patients to arterial, venous, or oxygenator thrombosis. Unfractionated heparin is the standard anticoagulant chosen in ECMO patients to prevent such complications.Case ReportIn this case report our patient presented heparin-induced thrombocytopenia (HIT), a possible complication.DiscussionAlternative strategies such as bivalirudin and argatroban are possible options but due the unavailability of those medications at our institution, nitric oxide (NO) via sweep-gas flow was deemed a reasonable alternative considering it's anti-aggregant effect.ConclusionThis case report details the use of NO as a possible alternative anticoagulant strategy in a patient with ECMO complicated by HIT.
{"title":"Nitric oxide in the ECMO circuit as a treatment option for heparin-induced thrombocytopenia: A case report.","authors":"Daniel Joelsons, Leonardo Van de Wiel Barros Urbano Andari, Pedro Paulo Zanella do Amaral Campos, Caroline Gomes Mól, Bruno de Arruda Bravim, Giles J Peek","doi":"10.1177/02676591261416014","DOIUrl":"https://doi.org/10.1177/02676591261416014","url":null,"abstract":"<p><p>IntroductionExtracorporeal membrane oxygenation (ECMO) involves the use of a synthetic circuit, which initiates a complex interplay of inflammatory and pro-coagulant responses. This intricate, self-reinforcing process results in a prothrombotic state, predisposing patients to arterial, venous, or oxygenator thrombosis. Unfractionated heparin is the standard anticoagulant chosen in ECMO patients to prevent such complications.Case ReportIn this case report our patient presented heparin-induced thrombocytopenia (HIT), a possible complication.DiscussionAlternative strategies such as bivalirudin and argatroban are possible options but due the unavailability of those medications at our institution, nitric oxide (NO) via sweep-gas flow was deemed a reasonable alternative considering it's anti-aggregant effect.ConclusionThis case report details the use of NO as a possible alternative anticoagulant strategy in a patient with ECMO complicated by HIT.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591261416014"},"PeriodicalIF":1.1,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.1177/02676591261420646
Manuj M Shah, Mitchell S Jay, Xiyu Zhao, Victor B Yang, Siam T Muquit, Chetan Pasrija, Antonio Polanco, Glenn Whitman, Bo Soo Kim, Sung-Min Cho, Babar Shafiq, Henry T Shu
PurposeExtracorporeal membrane oxygenation (ECMO) patients have increased risk for limb acute compartment syndrome (ACS), but diagnosis remains difficult given the lack of subjective and pulsatility assessments in this patient population. This exploratory study characterized ECMO patients who developed ACS and investigated laboratory measures that can aid diagnosis.MethodsWe reviewed records of adult patients placed on ECMO between 2016 and 2022 at our single center, collecting clinical, laboratory, and survival data upon cannulation. We performed comparisons of baseline and laboratory data between ACS and No ACS patients. Threshold regression was then used to develop laboratory cutoffs for ACS diagnosis and logistic regression to characterize predictors of ACS. Survival analysis relied on Cox proportional hazards modeling.Results278 ECMO patients were included, of which 14 (5%) developed ACS. ACS patients had a higher amputation rate (21.4% vs 1.9%, p < 0.001) and mortality risk (HR 2.35, p = 0.03); only 1 (7%) ACS patient had amputation-free survival. The most sensitive threshold cutoffs included maximum INR >1.95 (sensitivity 0.91), baseline lactate >7.85 (0.88), and 24-h lactate >3.75 (0.88). The most specific were baseline CpK >3765.5 (specificity 0.91), maximum K >5.95 (0.88), and maximum CpK >6362.0 (0.85). Laboratory values, namely CpK and lactate, predicted ACS with promising diagnostic sensitivity and specificity.ConclusionsACS remains associated with increased mortality and morbidity, most often occurring within 24 h after cannulation. Laboratory values, namely CpK and lactate values, independently predicted ACS development with promising sensitivity and specificity. These exploratory findings may help guide decision-making surrounding ACS in the ECMO setting.
目的体外膜氧合(ECMO)患者患肢体急性室室综合征(ACS)的风险增加,但由于缺乏主观和脉搏性评估,诊断仍然困难。本探索性研究描述了发生ACS的ECMO患者,并调查了有助于诊断的实验室措施。方法我们回顾了2016年至2022年在我们单一中心接受ECMO的成年患者的记录,收集了插管后的临床、实验室和生存数据。我们比较了ACS和非ACS患者的基线和实验室数据。然后使用阈值回归来开发ACS诊断的实验室截止点,并使用逻辑回归来表征ACS的预测因子。生存分析依赖于Cox比例风险模型。结果入选ECMO患者278例,其中14例(5%)发生ACS。ACS患者截肢率(21.4% vs 1.9%, p < 0.001)和死亡风险(HR 2.35, p = 0.03)较高;只有1例(7%)ACS患者无截肢生存。最敏感的阈值包括最大INR >1.95(敏感性0.91),基线乳酸>7.85(0.88),24小时乳酸>3.75(0.88)。特异性最高的是基线CpK bbb3765.5(特异性0.91)、最大CpK >5.95(特异性0.88)和最大CpK >6362.0(特异性0.85)。实验室值,即CpK和乳酸盐,预测ACS具有良好的诊断敏感性和特异性。结论sacs仍与死亡率和发病率增加有关,最常发生在插管后24 h内。实验室值,即CpK和乳酸值,独立预测ACS的发展,具有良好的敏感性和特异性。这些探索性发现可能有助于指导在ECMO环境下围绕ACS的决策。
{"title":"Laboratory factors and diagnostic aids for compartment syndrome in extracorporeal membrane oxygenation: An exploratory single-center study.","authors":"Manuj M Shah, Mitchell S Jay, Xiyu Zhao, Victor B Yang, Siam T Muquit, Chetan Pasrija, Antonio Polanco, Glenn Whitman, Bo Soo Kim, Sung-Min Cho, Babar Shafiq, Henry T Shu","doi":"10.1177/02676591261420646","DOIUrl":"https://doi.org/10.1177/02676591261420646","url":null,"abstract":"<p><p>PurposeExtracorporeal membrane oxygenation (ECMO) patients have increased risk for limb acute compartment syndrome (ACS), but diagnosis remains difficult given the lack of subjective and pulsatility assessments in this patient population. This exploratory study characterized ECMO patients who developed ACS and investigated laboratory measures that can aid diagnosis.MethodsWe reviewed records of adult patients placed on ECMO between 2016 and 2022 at our single center, collecting clinical, laboratory, and survival data upon cannulation. We performed comparisons of baseline and laboratory data between ACS and No ACS patients. Threshold regression was then used to develop laboratory cutoffs for ACS diagnosis and logistic regression to characterize predictors of ACS. Survival analysis relied on Cox proportional hazards modeling.Results278 ECMO patients were included, of which 14 (5%) developed ACS. ACS patients had a higher amputation rate (21.4% vs 1.9%, <i>p</i> < 0.001) and mortality risk (HR 2.35, <i>p</i> = 0.03); only 1 (7%) ACS patient had amputation-free survival. The most sensitive threshold cutoffs included maximum INR >1.95 (sensitivity 0.91), baseline lactate >7.85 (0.88), and 24-h lactate >3.75 (0.88). The most specific were baseline CpK >3765.5 (specificity 0.91), maximum K >5.95 (0.88), and maximum CpK >6362.0 (0.85). Laboratory values, namely CpK and lactate, predicted ACS with promising diagnostic sensitivity and specificity.ConclusionsACS remains associated with increased mortality and morbidity, most often occurring within 24 h after cannulation. Laboratory values, namely CpK and lactate values, independently predicted ACS development with promising sensitivity and specificity. These exploratory findings may help guide decision-making surrounding ACS in the ECMO setting.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591261420646"},"PeriodicalIF":1.1,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1177/02676591251415504
Elizabeth J Bashian, Thomas F O'Shea, Jordan R H Hoffman, Michael T Cain, Nicholas R Teman
BackgroundUtilization of extracorporeal membrane oxygenation (ECMO) has expanded substantially, yet structured training for surgical residents remain limited. We established a dedicated ECMO/mechanical circulatory support (MCS) fellowship for general surgery residents on dedicated academic time and evaluated its feasibility, educational impact, and association with institutional outcomes.MethodsA single-center retrospective review was performed comparing ECMO activity and outcomes before and after fellowship implementation. . Institutional outcomes were compared across pre-fellowship and fellowship eras. Fellows' clinical involvement was quantified through procedural logs and self-reported comfort levels. A multidisciplinary survey assessed perceptions of workflow, communication, and education using 5-point Likert scales and free-text feedback.ResultsTwo fellows completed the program during the study period. Since initiation, annual ECMO runs increased from 59 to 119 (+101%), with total ECMO hours rising 59%. The proportion of patients successfully weaned from ECMO improved significantly in 2025 compared with 2024 (59% vs 41%, χ2 = 6.12, p = 0.013), with a corresponding decline in on-support mortality (22% vs 37%). Two fellows matriculated, each participating in approximately 75 cannulations annually and reporting independent cannulation competency by year-end. Of approximately 70 eligible stakeholders, 30 responded (42%), with most agreeing the fellowship improved ECMO care (90%) and ICU-surgical communication (90%), though fewer endorsed reduced workload (43%). Open-ended feedback emphasized enhanced teamwork and continuity of care.ConclusionsEarly implementation of a dedicated ECMO/MCS fellowship for surgical residents was feasible and associated with increased program volume, improved interdisciplinary communication, and robust trainee experience. Early results suggest potential educational and institutional benefits, warranting longer-term evaluation.
体外膜氧合(ECMO)的应用已经大大扩大,但对外科住院医师的结构化培训仍然有限。我们为普通外科住院医师建立了专门的ECMO/机械循环支持(MCS)奖学金,并评估了其可行性、教育影响以及与机构结果的关联。方法采用单中心回顾性评价方法,比较联谊前后ECMO活动和结果。机构的结果在奖学金前和奖学金时期进行了比较。研究员的临床参与通过程序日志和自我报告的舒适度来量化。一项多学科调查评估了工作流程、沟通和教育的看法,使用五点李克特量表和自由文本反馈。结果在研究期间有2名研究员完成了该项目。自启动以来,每年ECMO运行次数从59次增加到119次(+101%),总ECMO小时增加了59%。与2024年相比,2025年成功脱离ECMO的患者比例显著提高(59% vs 41%, χ2 = 6.12, p = 0.013),相应的支持死亡率下降(22% vs 37%)。两名研究员被录取,每人每年参加大约75次插管,并在年底前报告独立的插管能力。在大约70名符合条件的利益相关者中,30名(42%)做出了回应,大多数人同意该奖学金改善了ECMO护理(90%)和icu -外科沟通(90%),尽管较少人赞同减少工作量(43%)。开放式反馈强调加强团队合作和护理的连续性。结论:早期实施专门的外科住院医师ECMO/MCS奖学金是可行的,并且与增加项目数量、改善跨学科交流和丰富的实习经验有关。早期的结果显示了潜在的教育和机构效益,需要长期的评估。
{"title":"Early impact of dedicated ECMO fellows on program outcomes.","authors":"Elizabeth J Bashian, Thomas F O'Shea, Jordan R H Hoffman, Michael T Cain, Nicholas R Teman","doi":"10.1177/02676591251415504","DOIUrl":"https://doi.org/10.1177/02676591251415504","url":null,"abstract":"<p><p>BackgroundUtilization of extracorporeal membrane oxygenation (ECMO) has expanded substantially, yet structured training for surgical residents remain limited. We established a dedicated ECMO/mechanical circulatory support (MCS) fellowship for general surgery residents on dedicated academic time and evaluated its feasibility, educational impact, and association with institutional outcomes.MethodsA single-center retrospective review was performed comparing ECMO activity and outcomes before and after fellowship implementation. . Institutional outcomes were compared across pre-fellowship and fellowship eras. Fellows' clinical involvement was quantified through procedural logs and self-reported comfort levels. A multidisciplinary survey assessed perceptions of workflow, communication, and education using 5-point Likert scales and free-text feedback.ResultsTwo fellows completed the program during the study period. Since initiation, annual ECMO runs increased from 59 to 119 (+101%), with total ECMO hours rising 59%. The proportion of patients successfully weaned from ECMO improved significantly in 2025 compared with 2024 (59% vs 41%, χ<sup>2</sup> = 6.12, p = 0.013), with a corresponding decline in on-support mortality (22% vs 37%). Two fellows matriculated, each participating in approximately 75 cannulations annually and reporting independent cannulation competency by year-end. Of approximately 70 eligible stakeholders, 30 responded (42%), with most agreeing the fellowship improved ECMO care (90%) and ICU-surgical communication (90%), though fewer endorsed reduced workload (43%). Open-ended feedback emphasized enhanced teamwork and continuity of care.ConclusionsEarly implementation of a dedicated ECMO/MCS fellowship for surgical residents was feasible and associated with increased program volume, improved interdisciplinary communication, and robust trainee experience. Early results suggest potential educational and institutional benefits, warranting longer-term evaluation.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591251415504"},"PeriodicalIF":1.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1177/02676591261416084
Mirte L Jansen, Nina C Boom, Nienke Schalij, Peter Paul Roeleveld, Eelco Van Es, Oliver Karam, Ariane Willems
IntroductionIn children undergoing Extracorporeal Membrane Oxygenation (ECMO), anticoagulation is given to counterbalance the risk of thrombosis. Several laboratory tests are available to monitor heparin, but the ideal method still needs to be determined.MethodsThis retrospective cohort study included all patients under 18 years on ECMO support between 2010 and 2021. At our institution, the test used to monitor unfractionated heparin changed over time, dividing patients into three periods, using either activated clotting time (ACT) (2010-2014), activated partial thromboplastin time (aPTT) (2014-2018) or anti-Xa (2018-2021). The primary objective was to compare the occurrence of hemorrhagic complications. Secondary objectives included thrombotic complications, neurological complications, and survival.ResultsWe included 118 ECMO runs of which 30 ACT-guided, 40 aPTT-guided, and 48 anti-Xa-guided. No statistically significant differences were found in hemorrhagic complications [respectively 46.7% vs. 52.5% vs. 60.4%; p = 0.48], thrombotic complications (p = 0.15), neurological complications (p = 0.13), or 30-days survival (p = 0.84). Duration of ECMO and length of hospital stay were both the shortest in the anti-Xa-guided group (respectively p = 0.02; p = 0.02). During ECMO, the anti-Xa-guided group received a higher unfractionated heparin dose compared to the aPTT- and ACT-guided group [respectively 839 [651-981] vs. 543 [407-692] vs. 330 [223-489] IU/kg d-1, p < 0.001].ConclusionIn our study, the test or titration method used to guide heparin-dosing in children on ECMO, was not associated with hemorrhagic complications and death. Of note, the dose of unfractionated heparin was significantly higher in the anti-Xa-guided group. Combined testing may be more effective than a single method, more studies are needed to establish the optimal strategy.
在接受体外膜氧合(ECMO)的儿童中,给予抗凝治疗以平衡血栓形成的风险。有几种实验室检测可用于监测肝素,但理想的方法仍有待确定。方法本回顾性队列研究纳入2010年至2021年期间接受ECMO支持的所有18岁以下患者。在我们的机构,用于监测未分离肝素的测试随时间而变化,将患者分为三个阶段,使用活化凝血时间(ACT)(2010-2014),活化部分凝血活素时间(aPTT)(2014-2018)或抗xa(2018-2021)。主要目的是比较出血性并发症的发生率。次要目标包括血栓性并发症、神经系统并发症和生存率。结果纳入118组ECMO,其中act引导30组,aptt引导40组,anti- xa引导48组。出血性并发症发生率差异无统计学意义[分别为46.7%∶52.5%∶60.4%;P = 0.48]、血栓性并发症(P = 0.15)、神经系统并发症(P = 0.13)或30天生存率(P = 0.84)。抗xa引导组ECMO持续时间最短,住院时间最短(p = 0.02; p = 0.02)。在ECMO期间,与aPTT和act引导组相比,抗xa引导组接受的未分割肝素剂量更高[分别为839[651-981]、543[407-692]、330 [223-489]IU/kg d-1, p < 0.001]。结论在我们的研究中,用于指导ECMO患儿肝素给药的试验或滴定方法与出血性并发症和死亡无关。值得注意的是,在抗xa引导组中,未分离肝素的剂量明显更高。联合测试可能比单一方法更有效,但需要更多的研究来确定最佳策略。
{"title":"Protocols for anticoagulation management in pediatric extracorporeal membrane oxygenation: A comparative retrospective study.","authors":"Mirte L Jansen, Nina C Boom, Nienke Schalij, Peter Paul Roeleveld, Eelco Van Es, Oliver Karam, Ariane Willems","doi":"10.1177/02676591261416084","DOIUrl":"https://doi.org/10.1177/02676591261416084","url":null,"abstract":"<p><p>IntroductionIn children undergoing Extracorporeal Membrane Oxygenation (ECMO), anticoagulation is given to counterbalance the risk of thrombosis. Several laboratory tests are available to monitor heparin, but the ideal method still needs to be determined.MethodsThis retrospective cohort study included all patients under 18 years on ECMO support between 2010 and 2021. At our institution, the test used to monitor unfractionated heparin changed over time, dividing patients into three periods, using either activated clotting time (ACT) (2010-2014), activated partial thromboplastin time (aPTT) (2014-2018) or anti-Xa (2018-2021). The primary objective was to compare the occurrence of hemorrhagic complications. Secondary objectives included thrombotic complications, neurological complications, and survival.ResultsWe included 118 ECMO runs of which 30 ACT-guided, 40 aPTT-guided, and 48 anti-Xa-guided. No statistically significant differences were found in hemorrhagic complications [respectively 46.7% vs. 52.5% vs. 60.4%; <i>p</i> = 0.48], thrombotic complications (<i>p</i> = 0.15), neurological complications (<i>p</i> = 0.13), or 30-days survival (<i>p</i> = 0.84). Duration of ECMO and length of hospital stay were both the shortest in the anti-Xa-guided group (respectively <i>p</i> = 0.02; <i>p</i> = 0.02). During ECMO, the anti-Xa-guided group received a higher unfractionated heparin dose compared to the aPTT- and ACT-guided group [respectively 839 [651-981] vs. 543 [407-692] vs. 330 [223-489] IU/kg d<sup>-1</sup>, <i>p</i> < 0.001].ConclusionIn our study, the test or titration method used to guide heparin-dosing in children on ECMO, was not associated with hemorrhagic complications and death. Of note, the dose of unfractionated heparin was significantly higher in the anti-Xa-guided group. Combined testing may be more effective than a single method, more studies are needed to establish the optimal strategy.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591261416084"},"PeriodicalIF":1.1,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1177/02676591261418525
Prakash P Punjabi
{"title":"Strength in numbers, strength in content: Raising the bar.","authors":"Prakash P Punjabi","doi":"10.1177/02676591261418525","DOIUrl":"https://doi.org/10.1177/02676591261418525","url":null,"abstract":"","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591261418525"},"PeriodicalIF":1.1,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1177/02676591251415338
Christopher Noel, Adam Green, Abhimanyu Chandel, Joseph Delio, Nitin Puri, Chase Donaldson, Craig Rackley, Steven A Conrad, Peter Rycus, Joseph E Tonna, Akram Zaaqoq, Justyna Swol, Christopher King
IntroductionOptimal sedation strategies for patients with respiratory failure requiring venovenous extracorporeal membrane oxygenation (VV ECMO) are not well defined.MethodsPhysicians caring for patients on ECMO in an intensive care unit were invited to complete an international survey about sedation and analgesia practices for adult patients undergoing VV ECMO for severe Acute Respiratory Distress Syndrome (ARDS).ResultsThe survey was completed by 234 physicians, most commonly identifying as critical care (29.9%) and practicing in North America (38.9%). The Richmond Agitation Sedation Scale (88.5%) and Clinical Pain Observation Tool (40.2%) were commonly used for monitoring. Agents of choice were propofol (73.9% prior to ECMO and 56% within 48 h after initiation) and fentanyl (57.3% and 40.2%), with increasing preference for dexmedetomidine after ECMO initiation (14.5% prior to and 25.6% after initiation). Routine neuromuscular blockade use beyond 48 h after cannulation was rare (1.3%). Common strategies to reduce sedatives included sweep gas titration (74.4%) and minimizing nocturnal interventions (63.7%). Most respondents believe antipsychotics also work to this effect (57.3%).ConclusionsSedation strategies for adult ARDS patients receiving VV ECMO seem to be influenced by time from cannulation and patient factors. Future research should focus on identifying optimal sedation strategies and developing a consensus for best practice.
{"title":"Sedation practices in adult patients with severe ARDS on extracorporeal respiratory support using VV ECMO - An international survey.","authors":"Christopher Noel, Adam Green, Abhimanyu Chandel, Joseph Delio, Nitin Puri, Chase Donaldson, Craig Rackley, Steven A Conrad, Peter Rycus, Joseph E Tonna, Akram Zaaqoq, Justyna Swol, Christopher King","doi":"10.1177/02676591251415338","DOIUrl":"https://doi.org/10.1177/02676591251415338","url":null,"abstract":"<p><p>IntroductionOptimal sedation strategies for patients with respiratory failure requiring venovenous extracorporeal membrane oxygenation (VV ECMO) are not well defined.MethodsPhysicians caring for patients on ECMO in an intensive care unit were invited to complete an international survey about sedation and analgesia practices for adult patients undergoing VV ECMO for severe Acute Respiratory Distress Syndrome (ARDS).ResultsThe survey was completed by 234 physicians, most commonly identifying as critical care (29.9%) and practicing in North America (38.9%). The Richmond Agitation Sedation Scale (88.5%) and Clinical Pain Observation Tool (40.2%) were commonly used for monitoring. Agents of choice were propofol (73.9% prior to ECMO and 56% within 48 h after initiation) and fentanyl (57.3% and 40.2%), with increasing preference for dexmedetomidine after ECMO initiation (14.5% prior to and 25.6% after initiation). Routine neuromuscular blockade use beyond 48 h after cannulation was rare (1.3%). Common strategies to reduce sedatives included sweep gas titration (74.4%) and minimizing nocturnal interventions (63.7%). Most respondents believe antipsychotics also work to this effect (57.3%).ConclusionsSedation strategies for adult ARDS patients receiving VV ECMO seem to be influenced by time from cannulation and patient factors. Future research should focus on identifying optimal sedation strategies and developing a consensus for best practice.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591251415338"},"PeriodicalIF":1.1,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1177/02676591251407293
Eiman Shah, Jan Spillner, Johannes Greven, Annika Schmitz, Andreas Horbach, Yvan Fournier, Mehdi Behbahani
IntroductionPulmonary artery (PA) cannulation is emerging as a method for concurrent cardiac and respiratory failure, but limited data exists on how cannula positioning, particularly cannula tip angle, affects perfusion symmetry. Due to varying pulmonary bifurcation geometry between patients, ensuring even distribution of oxygen-saturated blood becomes critical. This computational fluid dynamics (CFD) study investigated the effects of cannula positioning and angles on oxygen delivery within the PA using 6 different configurations.MethodAn idealized PA geometry based on a CT scan was constructed including the 6 different cannula configurations: two straight (short and long) and four angled (5° and 10° toward either pulmonary branch). Simulations assumed laminar, steady-state flow at 6 L/min total (50% ECMO contribution). Oxygen transport was modeled as a passive scalar with 75% saturation from the heart and 100% from the cannula. Perfusion symmetry was quantified using the absolute difference in mean oxygen saturation (ΔSaO2) and partial pressure (ΔpO2) between the right (RPA) and left pulmonary arteries (LPA).ResultsCannula positioning and angulation influences oxygen distribution within the PA. Straight-tipped cannulas favored LPA-sided flow due to the natural geometry of the pulmonary artery (ΔSaO2 = 12.9-15.1%). A 5° RPA directed angulation achieved the most symmetric distribution (ΔSaO2 = 9.2%, ΔpO2 = 14.2 mmHg), whereas greater or opposite angulations increased flow asymmetry.ConclusionMinor cannula tip angulation, specifically 5° deflection towards the RPA, enhances bilateral PA oxygenation without increasing ECMO flow, providing a simple yet effective strategy for optimizing pulmonary ECMO perfusion.
{"title":"Investigating cannula tip angles in pulmonary artery ECMO: A computational study on the potential benefits of angulation for oxygen delivery.","authors":"Eiman Shah, Jan Spillner, Johannes Greven, Annika Schmitz, Andreas Horbach, Yvan Fournier, Mehdi Behbahani","doi":"10.1177/02676591251407293","DOIUrl":"https://doi.org/10.1177/02676591251407293","url":null,"abstract":"<p><p>IntroductionPulmonary artery (PA) cannulation is emerging as a method for concurrent cardiac and respiratory failure, but limited data exists on how cannula positioning, particularly cannula tip angle, affects perfusion symmetry. Due to varying pulmonary bifurcation geometry between patients, ensuring even distribution of oxygen-saturated blood becomes critical. This computational fluid dynamics (CFD) study investigated the effects of cannula positioning and angles on oxygen delivery within the PA using 6 different configurations.MethodAn idealized PA geometry based on a CT scan was constructed including the 6 different cannula configurations: two straight (short and long) and four angled (5° and 10° toward either pulmonary branch). Simulations assumed laminar, steady-state flow at 6 L/min total (50% ECMO contribution). Oxygen transport was modeled as a passive scalar with 75% saturation from the heart and 100% from the cannula. Perfusion symmetry was quantified using the absolute difference in mean oxygen saturation (ΔSaO<sub>2</sub>) and partial pressure (ΔpO<sub>2</sub>) between the right (RPA) and left pulmonary arteries (LPA).ResultsCannula positioning and angulation influences oxygen distribution within the PA. Straight-tipped cannulas favored LPA-sided flow due to the natural geometry of the pulmonary artery (ΔSaO<sub>2</sub> = 12.9-15.1%). A 5° RPA directed angulation achieved the most symmetric distribution (ΔSaO<sub>2</sub> = 9.2%, ΔpO<sub>2</sub> = 14.2 mmHg), whereas greater or opposite angulations increased flow asymmetry.ConclusionMinor cannula tip angulation, specifically 5° deflection towards the RPA, enhances bilateral PA oxygenation without increasing ECMO flow, providing a simple yet effective strategy for optimizing pulmonary ECMO perfusion.</p>","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":" ","pages":"2676591251407293"},"PeriodicalIF":1.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145967739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}